試す - 無料

THE HIDDEN RISKS OF AMERICA'S MOST POPULAR PRESCRIPTION PAINKILLER

Mint Mumbai

|

December 26, 2025

Gabapentin has soared in popularity as an alternative to opioids, but patients are finding it can cause harm

- Betsy McKay & Shalini Ramachandran

THE HIDDEN RISKS OF AMERICA'S MOST POPULAR PRESCRIPTION PAINKILLER

While the medical establishment has mostly maintained that gabapentin isn't habit-forming, some patients have reported debilitating adverse effects when they try to taper off it.

(istockphoto)

John Avery was just back from a guys’ golfing weekend and doing dead lifts at the gym in 2023 when he felt a pop in his lower back. A disc had slipped and was pressing on a nerve.

After months of rest, physical therapy and steroids, he was prescribed a drug called gabapentin by a pain management specialist who told Avery that it could help calm his nerve pain and that it was “nonaddictive,” Avery recalled. He took the medicine for a few days, then had surgery, and took it again for a little more than three weeks.

The 33-year-old former high-school physical education teacher in Newark, Ill., said he experienced a severe protracted withdrawal when he stopped, which led to neurological symptoms now that make his original back problem seem like “a paper cut” by comparison.

His symptoms include shaking and a burning sensation throughout his body, muscle spasms and a racing pulse. He can’t sleep for more than a half-hour at a time, and has lost so much weight that his wife said his calves are the size of her arms.

The change in his life, he said, is “beyond dramatic.”

Approved by the Food and Drug Administration decades ago for seizures and nerve pain from shingles, gabapentin is now the seventh-most widely prescribed drug in the U.S., according to the Iqvia Institute for Human Data Science. About 15.5 million people were prescribed gabapentin in 2024, according to an analysis by Centers for Disease Control and Prevention researchers.

Studies show that most of the prescriptions are written to treat conditions that it wasn't approved for—a practice that is legal and common, but means the FDA hasn't vetted its risks and benefits for those purposes.

Mint Mumbai からのその他のストーリー

Mint Mumbai

Simulation or not, Musk’s surreal year could push him to $1 trillion heights

It can be hard to understand Elon Musk's reality—especially as he appears to be on track to become the world's first trillionaire this year.

time to read

4 mins

January 06, 2026

Mint Mumbai

M&M, Tata embrace Chinese pace to win

To win market share from rivals in the domestic market, homegrown carmakers Tata Motors and Mahindra & Mahindra have borrowed from the Chinese playbook: churn out new models at an accelerated pace.

time to read

2 mins

January 06, 2026

Mint Mumbai

Govt may nudge cities to chart their own destinies

Plan is to strengthen local bodies' revenue sources like property tax, user charges

time to read

4 mins

January 06, 2026

Mint Mumbai

WILL INDIA'S NUCLEAR POWER PIVOT PAY OFF?

One of the most significant policy moves of 2025 was the passage of the Sustainable Harnessing and Advancement of Nuclear Energy for Transforming India (SHANTI) Bill, which overhauled India's nuclear manufacturing and fuel-cycle services-to private players, while easing liability provisions that had deterred foreign suppliers and investors.

time to read

3 mins

January 06, 2026

Mint Mumbai

Shrug and carry on

Even as extended negotiations go on between Washington and New Delhi on trade, US President Donald Trump seems to have thrown another spanner in the works.

time to read

1 min

January 06, 2026

Mint Mumbai

Mint Mumbai

E-bus tender done, CESL now looks at electric trucks

Convergence Energy Services Ltd (CESL), the Centre’s demand aggregation agency, wants the government to name it as nodal agency for tendering electric trucks under the ₹10,900-crore PME-Drive scheme, two people aware of the development said.

time to read

1 mins

January 06, 2026

Mint Mumbai

Why we urgently need a national competition policy

India’s economy is at an inflection point.

time to read

3 mins

January 06, 2026

Mint Mumbai

Lou Gerstner: The CEO who taught IBM how to dance

Louis Vincent Gerstner Jr., the American business leader whose steady hand and clear-sighted strategy pulled International Business Machines Corp (IBM) from the brink of collapse and reshaped it for the dawn of the digital age, died on 27 December 2025 at his home in Jupiter, Florida.

time to read

3 mins

January 06, 2026

Mint Mumbai

Mint Mumbai

Plan to eat better this year? Here’s what to focus on

To get healthier in the new year, prioritize protein and fibre, don't count calories, and eat intentionally, say experts

time to read

3 mins

January 06, 2026

Mint Mumbai

The hidden cost of blindly chasing MF leaderboards and past returns

How market cycles and styles keep reshaping mutual fund rankings, and why recent performance rarely repeats

time to read

5 mins

January 06, 2026

Listen

Translate

Share

-
+

Change font size